Tembexa Suspension
Product Images NDC 64678-012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 64678-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biodefense Operations Lansing Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Brincidofovir, the active ingredient in Tembexa oral suspension, showing its molecular framework including nitrogen, oxygen, phosphorus atoms, and the extended alkyl chain.*

FDA Label Image

Oral Suspension Carton Label (Image 02)

Label for Tembexa (brincidofovir) oral suspension, 10 mg/mL, manufactured by Emergent BioDefense Operations Lansing LLC. The label includes dosing instructions, storage temperatures, ingredients, and safety warnings. The 65 mL suspension is for oral use, Rx only, with active ingredient brincidofovir detailed, and a barcode present.*

FDA Label Image

Oral Suspension Bottle Label (Image 03)

Label for Tembexa (Brincidofovir) oral suspension, 10 mg/mL, manufactured by Emergent BioDefense Operations Lansing LLC. The label indicates it is for oral use, prescription only, with a package content of 65 mL. Storage instructions specify controlled room temperature protection and avoidance of freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.